Ultrasound-mediated drug delivery for cardiovascular disease.
about
SonothrombolysisAdvance of molecular imaging technology and targeted imaging agent in imaging and therapyShaken and stirred: mechanisms of ultrasound-enhanced thrombolysis.Comparative lytic efficacy of rt-PA and ultrasound in porcine versus human clotsLow Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles.Dynamic Behavior of Microbubbles during Long Ultrasound Tone-Burst Excitation: Mechanistic Insights into Ultrasound-Microbubble Mediated Therapeutics Using High-Speed Imaging and Cavitation Detection.Trans-Stent B-Mode Ultrasound and Passive Cavitation Imaging.Microfluidic manufacture of rt-PA -loaded echogenic liposomes.Loss of echogenicity and onset of cavitation from echogenic liposomes: pulse repetition frequency independence.The delayed onset of subharmonic and ultraharmonic emissions from a phospholipid-shelled microbubble contrast agentPulsed ultrasound enhances the delivery of nitric oxide from bubble liposomes to ex vivo porcine carotid tissue.Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents.Recent advancements in the cardiovascular drug carriers.Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes.Focal areas of increased lipid concentration on the coating of microbubbles during short tone-burst ultrasound insonification.Loss of gas from echogenic liposomes exposed to pulsed ultrasound.An in vitro proof-of-principle study of sonobactericide.Design of an ultrasonic physiotherapy system with pulse wave feedback control.Click-Chemistry-Mediated Rapid Microbubble Capture for Acute Thrombus Ultrasound Molecular Imaging.In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressures
P2860
Q26781198-C7AE8E38-AB06-4CC4-96CD-31FB0C5629B0Q26851887-15AF41C7-9C7A-4A9D-869C-423940AC82ECQ27303116-64055A31-9479-441E-81DA-593871A05D79Q30355737-80BC5036-FC0A-46A5-AE46-2B1064E691CDQ30359572-417E7176-1492-49AC-AFB1-C3EDBF20F1D7Q30364813-40DCB737-64D2-4081-859D-197CC8A8AC61Q30364821-8F7E471A-117D-49F6-8A3D-3A679EBA9B0EQ30380882-9B98F968-9B55-4444-AEBA-D356F682657DQ30395085-6B4C8E09-CC40-4C76-AC00-D026710D1584Q30415646-3550B413-70CC-422C-B2A5-ED985D8C50BFQ30428065-59107E20-8403-41E2-AD1F-F643F7DB740CQ30438378-E2858AED-0951-40C3-8E2F-9F09663A2A04Q38232209-E22276CC-7AB7-41C5-BE4B-BB2619561261Q38816063-6ABE6F92-34D6-46DB-9AB7-C488B4E5CBFBQ40960427-1F4F5A11-CFF3-4555-8E63-4C680D7030FAQ46942228-2C783A4B-E793-4F6A-8DB1-525EAD586B85Q50282142-7F5F52EE-6932-432F-99C1-C76722F76A0EQ50600838-2339D7B3-BC63-4702-B238-AF0D3091B20CQ50655505-8BD6188C-7BD6-41AD-9C29-4B3D440AF884Q53589220-660A40FD-008B-4820-982B-B5B732C7CE1EQ57154180-AE58AFFD-4A8C-451A-898D-7C9558A23F93
P2860
Ultrasound-mediated drug delivery for cardiovascular disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ultrasound-mediated drug delivery for cardiovascular disease.
@ast
Ultrasound-mediated drug delivery for cardiovascular disease.
@en
type
label
Ultrasound-mediated drug delivery for cardiovascular disease.
@ast
Ultrasound-mediated drug delivery for cardiovascular disease.
@en
prefLabel
Ultrasound-mediated drug delivery for cardiovascular disease.
@ast
Ultrasound-mediated drug delivery for cardiovascular disease.
@en
P2860
P50
P1476
Ultrasound-mediated drug delivery for cardiovascular disease
@en
P2093
Gail Pyne-Geithman
P2860
P304
P356
10.1517/17425247.2013.772578
P407
P577
2013-03-01T00:00:00Z